why choose us

First received: October 31, 2023

Clinical Trial: Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Hemophilia B Without Inhibitor

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Brief Summary: This is an open- label, non- randomized, uncontrolled, dose-escalation pilot study to evaluate the safety and efficacy of KL001 injection solution in hemophilia B subjects with ?2 IU/dl residual FIX levels.

Read more